Bioxytran, Inc.
USD0.03
-0.00 (-0.00%)
CEO
David Platt
IPO Date
2010-01-05
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.03
Prev. Close
$0.03
Day Low
$0.03
Day High
$0.03
52W Low
$0.03
52W High
$0.11
Market Cap
$0.00B
Volume
0.03M
| -5.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 176.1% | -3109.6% | -0.79 | 0.01 | -4.7 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 91.2% | -664.2% | -0.80 | 0.08 | -22.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 157.4% | -3642.7% | -0.77 | 0.02 | -9.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 132.7% | -1150.2% | -0.57 | 0.14 | -6.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 260.9% | -949.6% | -1.06 | 0.22 | -11.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 131.6% | -814.1% | -1.01 | 0.14 | -146.4 |
| 31 Dec 2017 | FY | 45.6% | -166.6% | -58.7% | -43.9% | 0.20 | 0.24 | -8.7 |
| 31 Dec 2016 | FY | 60.9% | -282.7% | 239.8% | -1348.4% | -0.38 | 0.08 | -0.7 |
| -3.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 9.7% | -180.9% | -0.29 | 0.00 | -5.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -1.3% | 24.0% | -0.51 | 0.00 | 65.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 50.0% | -994.9% | -0.47 | 0.00 | -0.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 28.6% | -369.4% | -0.61 | 0.00 | -6.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 36.2% | -246.8% | -0.86 | 0.03 | -8.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 163.1% | -514.7% | -2.07 | 0.01 | -6.5 |
| 31 Mar 2024 | Q1 | 93.2% | -2680.1% | 270.2% | -637.5% | -3.28 | 0.01 | -5.6 |
| 31 Dec 2023 | Q4 | 103.2% | 885.1% | 43.0% | -760.3% | -0.79 | 0.01 | -5.2 |